利妥昔单抗作为难治性慢性移植物抗宿主病的挽救治疗方法。 - Suppr

Suppr

超能文献

Rituximab as salvage therapy for refractory chronic GVHD.

作者信息

Mohty M, Marchetti N, El-Cheikh J, Faucher C, Fürst S, Blaise D

出版信息

Bone Marrow Transplant. 2008 May;41(10):909-11. doi: 10.1038/bmt.2008.12. Epub 2008 Feb 18.

DOI:10.1038/bmt.2008.12

PMID:18278073

Abstract

摘要

相似文献

Rituximab as salvage therapy for refractory chronic GVHD.利妥昔单抗作为难治性慢性移植物抗宿主病的挽救治疗方法。

Bone Marrow Transplant. 2008 May;41(10):909-11. doi: 10.1038/bmt.2008.12. Epub 2008 Feb 18.

Treatment of refractory chronic GVHD with rituximab: a GITMO study.利妥昔单抗治疗难治性慢性移植物抗宿主病：一项全球免疫肿瘤学研究组（GITMO）的研究

Bone Marrow Transplant. 2007 Aug;40(3):273-7. doi: 10.1038/sj.bmt.1705725. Epub 2007 Jun 4.

Clinical utility of rituximab in chronic graft-versus-host disease.利妥昔单抗在慢性移植物抗宿主病中的临床应用

Ann Pharmacother. 2009 Feb;43(2):316-21. doi: 10.1345/aph.1L386. Epub 2009 Feb 3.

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab.低剂量利妥昔单抗治疗慢性类固醇难治性移植物抗宿主病

Transplantation. 2008 Sep 27;86(6):875-9. doi: 10.1097/TP.0b013e318183f662.

Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients.

Bone Marrow Transplant. 2008 Feb;41(4):409-10. doi: 10.1038/sj.bmt.1705927. Epub 2007 Nov 19.

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.R-ESHAP方案作为复发或难治性弥漫性大B细胞淋巴瘤患者的挽救治疗：既往使用利妥昔单抗对疗效的影响。一项GEL/TAMO研究。

Haematologica. 2008 Dec;93(12):1829-36. doi: 10.3324/haematol.13440. Epub 2008 Oct 22.

Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide.

Exp Hematol. 2009 Jun;37(6):767-73. doi: 10.1016/j.exphem.2009.03.006.

Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.难治性白血病异基因造血干细胞移植中预防移植物抗宿主病的序贯强化预处理及预防性免疫抑制剂的减量

Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85. doi: 10.1016/j.bbmt.2009.06.017. Epub 2009 Aug 19.

Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.利妥昔单抗和/或自体移植大剂量治疗对滤泡性淋巴瘤患者复发时的影响：一项GELA研究

J Clin Oncol. 2008 Jul 20;26(21):3614-20. doi: 10.1200/JCO.2007.15.5358. Epub 2008 Jun 16.

Rituximab responsive refractory acute graft-versus-host disease.

Biol Blood Marrow Transplant. 2006 Nov;12(11):1201-2. doi: 10.1016/j.bbmt.2006.06.013.

引用本文的文献

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies.利妥昔单抗在降低强度预处理方案中添加对 B 细胞恶性肿瘤并无影响：异基因造血干细胞移植治疗 B 细胞恶性肿瘤后的 EBMT 登记分析。

Front Immunol. 2021 Feb 2;11:613954. doi: 10.3389/fimmu.2020.613954. eCollection 2020.

Modifying Graft-versus-Host Disease in a Humanized Mouse Model by Targeting Macrophages or B-Cells.通过靶向巨噬细胞或 B 细胞在人源化小鼠模型中修饰移植物抗宿主病。

J Immunol Res. 2019 May 8;2019:3538963. doi: 10.1155/2019/3538963. eCollection 2019.

The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.B细胞靶向在慢性移植物抗宿主病中的作用

Biomedicines. 2017 Oct 17;5(4):61. doi: 10.3390/biomedicines5040061.

Biology of chronic graft--host disease: Immune mechanisms and progress in biomarker discovery.慢性移植物抗宿主病的生物学：免疫机制与生物标志物发现进展

World J Transplant. 2016 Dec 24;6(4):608-619. doi: 10.5500/wjt.v6.i4.608.

Autoimmune-like hepatitis after allogeneic hematopoietic stem cell transplantation: humoral hepatic GvHD.异基因造血干细胞移植后类似自身免疫性肝炎：体液性肝脏移植物抗宿主病

Bone Marrow Transplant. 2017 Jan;52(1):151-153. doi: 10.1038/bmt.2016.202. Epub 2016 Aug 15.

Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors.非清髓性异基因骨髓移植治疗B细胞淋巴瘤的II期研究，移植后使用利妥昔单抗并首先基于非HLA因素进行供体选择。

Biol Blood Marrow Transplant. 2015 Dec;21(12):2115-2122. doi: 10.1016/j.bbmt.2015.07.012. Epub 2015 Jul 14.

Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.根据 NIH 标准定义的大样本慢性移植物抗宿主病患者中自身抗体的临床意义。

Am J Hematol. 2015 Feb;90(2):114-9. doi: 10.1002/ajh.23885. Epub 2014 Nov 24.

Increased BCR responsiveness in B cells from patients with chronic GVHD.慢性移植物抗宿主病患者 B 细胞中 BCR 反应性增强。

Blood. 2014 Mar 27;123(13):2108-15. doi: 10.1182/blood-2013-10-533562. Epub 2014 Feb 14.

Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.利妥昔单抗预防异基因外周血造血干细胞移植后需要皮质类固醇治疗的慢性移植物抗宿主病：一项 2 期试验的结果。

Blood. 2013 Aug 22;122(8):1510-7. doi: 10.1182/blood-2013-04-495895. Epub 2013 Jul 16.

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.慢性移植物抗宿主病患者的 B 细胞通过 BAFF 介导的途径被激活和为存活做好准备。

Blood. 2012 Sep 20;120(12):2529-36. doi: 10.1182/blood-2012-06-438911. Epub 2012 Aug 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验